Literature DB >> 93049

HLA B27 and defects in the T-cell system in Whipple's disease.

G E Feurle, B Dörken, E Schöpf, V Lenhard.   

Abstract

The cellular immune system was tested in nine patients with Whipples' disease. Three patients had active disease, and six had been in remission for up to 10 years. Intradermal delayed hypersensitivity reactions to candidin, trichophytin, tuberculin and varidase, T-cell counts as determined by E-rosettes, allogeneic stimulation of lymphocytes in the mixed lymphocyte culture, and mitogenic activation of lymphocytes by concanavalin A, phytohaemagglutinin and by pokeweed mitogen, were tested in the patients and compared with control subjects. HLA typing was performed in all patients. The reaction to tuberculin and varidase, the T-cell counts and the activation of lymphocytes by concanavalin A were significantly reduced in patients with active disease and in patients during remission. The reaction to candidin and trichophytin was poor even in the controls. The mean results of the mixed lymphocyte culture, phytohaemagglutinin, and pokeweed mitogen activation tests were not significantly different from the controls. In patients with active disease the mixed lymphocyte culture reaction and the T-cell counts were less than in patients in remission. The results suggest a persistent defect of T-cells in patients with Whipple's disease, a defect that is more severe in patients with active disease. The finding of HLA B27 in four of thenine patients supports the hypothesis of primary rather than secondary impairment of the cellular immune system in Whipple's disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93049     DOI: 10.1111/j.1365-2362.1979.tb00901.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

Review 1.  The diagnosis and treatment of Whipple's disease.

Authors:  T Marth
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 2.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Whipple's disease in a father-son pair.

Authors:  Maurizio Ponz de Leon; Athos Borghi; Francesca Ferrara; Miranda Contri; Luca Roncucci
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

5.  Is there an immune deficit in Whipple's disease?

Authors:  W O Dobbins
Journal:  Dig Dis Sci       Date:  1981-03       Impact factor: 3.199

6.  [Immunologic and electron microscopic findings in an unusual case of Whipple's disease].

Authors:  K P Stock; G R Burmester; J R Kalden; H Schmidt; J F Riemann
Journal:  Klin Wochenschr       Date:  1985-02-15

7.  Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease.

Authors:  A Kalt; T Schneider; S Ring; J Hoffmann; M Zeitz; A Stallmach; D H Persing; T Marth
Journal:  Int J Colorectal Dis       Date:  2005-05-05       Impact factor: 2.571

8.  Extraintestinal lymphoma in association with Whipple's disease.

Authors:  C D Gillen; R Coddington; P G Monteith; R H Taylor
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

9.  Chronic interstitial nephritis in Whipple's disease.

Authors:  A Schlumpf; U A Marbet; E Stöcklin; W Wegmann; B Lämmle; M Mujagic; W Jösch; G Thiel; H Thölen; W Olivieri; F Gudat; J Torhorst; H U Zollinger; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-01-03

10.  An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole.

Authors:  G E Feurle; T Marth
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.